-
ZERO-SHOT LUNG CANCER RISK PREDICTION?FROM?LONGITUDINAL?ELECTRONIC?HEALTH RECORDS?WITH CHAIN-OF-AGENTS?FRAMEWORK
Mar 18, 2026, 21:38 PM -
TREATMENT PATTERNS AMONG PEOPLE NEWLY DIAGNOSED WITH NARCOLEPSY TYPE 1 IN THE UNITED STATES: A REAL-WORLD DATA STUDY
Mar 18, 2026, 21:38 PM -
REAL-WORLD CHARACTERISTICS AND HEALTHCARE RESOURCE USE IN PATIENTS WITH AXIAL SPONDYLOARTHRITIS TREATED WITH BIMEKIZUMAB IN SWEDEN: THE BIMENORDIX STUDY
Mar 18, 2026, 21:38 PM -
AN AI-DRIVEN RANDOM SURVIVAL FOREST MODEL FOR PREDICTING CANCER-SPECIFIC SURVIVAL IN PEDIATRIC NEUROBLASTOMA: A SEER ANALYSIS
Mar 18, 2026, 21:38 PM -
PREFERENCES FOR LONG-ACTING PREP SIDE EFFECTS AMONG MEN WHO HAVE SEX WITH MEN IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
ENHANCING RESILIENCE AND MENTAL WELL-BEING AMONG PEDIATRIC NURSES: A SYSTEMATIC REVIEW OF EFFECTIVE STRATEGIES AND IMPLEMENTATION CHALLENGES
Mar 18, 2026, 21:38 PM -
ACCEPTABILITY OF IMMATURE SURVIVAL DATA IN HEALTH TECHNOLOGY ASSESSMENT DECISION-MAKING IN FRANCE AND GERMANY
Mar 18, 2026, 21:38 PM -
ECONOMIC BURDEN OF LOWER EXTREMITY ENDOVASCULAR REINTERVENTION IN PATIENTS WITH PERIPHERAL ARTERY DISEASE: A REAL-WORLD COST ANALYSIS
Mar 18, 2026, 21:38 PM -
QUALITY OF LIFE IN PATIENTS WITH METASTATIC CASTRATION RESISTANT PROSTATE CANCER: AN IRONMAN REGISTRY ANALYSIS
Mar 18, 2026, 21:38 PM -
CAN ARTIFICIAL INTELLIGENCE ASSISTED SYSTEMATIC LITERATURE REVIEW SUPPORT RIGOROUS EVIDENCE GENERATION? A CASE STUDY ON PREDICTORS OF COPD EXACERBATIONS
Mar 18, 2026, 21:38 PM -
DISPARITY IMPLICATIONS OF MACHINE-LEARNING-BASED MTM ELIGIBILITY CRITERIA
Mar 18, 2026, 21:38 PM -
WHAT CAN SOCIAL DRIVERS OF HEALTH DATA TELL US ABOUT HEALTH PLAN MEMBERS IN A LARGE REAL-WORLD DATABASE?
Mar 18, 2026, 21:38 PM -
MACHINE LEARNING-BASED PREDICTION OF PULMONARY ARTERIAL HYPERTENSION USING REAL-WORLD EHR AND CLAIMS DATA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS ANALYSIS OF RELMACABTAGENE AUTOLEUCEL VERSUS IMMUNOCHEMOTHERAPY IN PATIENTS WITH RELAPSED OR REFRACTORY LARGE B-CELL LYMPHOMA (R/R LBCL) WHO HAVE FAILED AT LEAST TWO LINES OF SYSTEMIC THERAPY IN CHINA
Mar 18, 2026, 21:38 PM -
COMPARISON OF POSTOPERATIVE ATRIAL FIBRILLATION, STROKE, MORTALITY, AND ECONOMIC OUTCOMES IN LOW-RISK TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR) PATIENTS: A SYSTEMATIC REVIEW USING THE PARTNER 3 TRIAL AS A COMPARATOR TO REAL-WORLD EVIDENCE
Mar 18, 2026, 21:38 PM -
DECLINING BASELINE HBA1C AT GLP-1 RECEPTOR AGONIST INITIATION IN U.S. ADULTS WITH TYPE 2 DIABETES, 2015-2024
Mar 18, 2026, 21:38 PM -
ECONOMIC IMPACT OF DELAYED ACCESS TO FINERENONE DUE TO FORMULARY RESTRICTIONS IN CHRONIC KIDNEY DISEASE (CKD) AND TYPE 2 DIABETES (T2D)
Mar 18, 2026, 21:38 PM -
MIND THE MORTALITY GAP: COMPARING AVERAGE AND AGE-DISTRIBUTION APPROACHES TO ESTIMATING BACKGROUND SURVIVAL FOR HEALTH ECONOMIC MODELS
Mar 18, 2026, 21:38 PM -
COMPARATIVE EFFECTIVENESS OF SGLT2 INHIBITORS VERSUS RAAS BLOCKERS IN SLOWING CKD PROGRESSION AMONG PATIENTS WITH DIABETIC NEPHROPATHY: INSIGHTS FROM REAL WORLD DATA
Mar 18, 2026, 21:38 PM -
CORTICOSTEROID AND BIOLOGIC USE IN A REAL-WORLD POPULATION WITH GENERALIZED MYASTHENIA GRAVIS IN THE UNITED STATES AND GERMANY
Mar 18, 2026, 21:38 PM
